Expected Spesolimab Plasma Exposure following Intravenous and Subcutaneous Dosing in Patients with Generalized Pustular Psoriasis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 2, p. s359, 2024. DOI: 10.25251/skin.8.supp.359. Disponível em: https://skin.dermsquared.com/skin/article/view/2655. Acesso em: 19 may. 2025.